Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs midazolam + fentanyl for sedation during EBUS-TBNA (KURM007)
jRCTs051210131Phase 3Completed
- Start
- Dec 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchial carcinoma, mediastinal mass and Mediastinal lymphadenopathy (MLAD) comparing Midazolam + placebo with Midazolam + fentanyl (2 arms). Primary endpoint: Composite procedural success (strict criteria). Started Dec 2021; status: completed.
02
Drugs
midazolamfentanyl
03
Conditions
bronchial carcinomamediastinal massMediastinal lymphadenopathy (MLAD)
Beyond the preview
Go deeper on jRCTs051210131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210131.